Intermedios farmacéuticos Crecimiento del mercado, tamaño, participación, tendencias, análisis de actores clave y pronóstico hasta 2028

  • Report Code : TIPRE00005559
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 185
Buy Now

 

Se espera que el mercado de productos intermedios farmacéuticos alcance los 37.290,33 millones de dólares en 2028 desde los 27.356,70 millones de dólares en 2020. Se estima que el mercado crecerá con una tasa compuesta anual del 4,2% entre 2021 y 2028.

 

El mercado de productos intermedios farmacéuticos se ha analizado según el tipo, la aplicación, el canal de distribución y la región. El mercado basado en la región está segmentado en América del Norte, Europa, Asia Pacífico, Oriente Medio y África, y América del Sur y Central. El informe hace hincapié en parámetros como las tendencias del mercado, los avances tecnológicos, la dinámica del mercado y el análisis del panorama competitivo de la empresa líder para ofrecer información y un análisis en profundidad del mercado de productos intermedios farmacéuticos. También incluye el análisis de la pandemia de COVID-19 en todo el mercado en todas las regiones clave.

 

Personalice la investigación para adaptarla a sus necesidades

Podemos optimizar y adaptar el análisis y el alcance que no se cumplen a través de nuestras ofertas estándar. Esta flexibilidad le ayudará a obtener la información exacta que necesita para la planificación y la toma de decisiones de su negocio.

Mercado de productos intermedios farmacéuticos: ideas estratégicas

Mercado de productos intermedios farmacéuticos
  • Pharmaceutical Intermediates Market
    CAGR (2020 - 2028)
    4,2%
  • Tamaño del mercado 2020
    US$ 27,36 mil millones
  • Tamaño del mercado 2028
    US$ 37,29 mil millones

Dinámica del mercado

CONTROLADORES DE CRECIMIENTO
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
FUTURAS TENDENCIAS
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
OPORTUNIDADES
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX

Jugadores claves . Jugadores principales

  •  
  • Pfizer Inc.
  • sanofi
  • BASF SE
  • Tecnología química Co., Ltd de Lianhe
  • Dishman Carbogen Amcis Ltd.
  • códice
  • Midas Pharma GmbH
  • Chiracon GmbH
  • Laboratorios Dextra Limited

Panorama regional

Pharmaceutical Intermediates Market
  • América del norte
  • Europa
  • Asia-Pacífico
  • América del Sur y Central
  • Medio Oriente y África

Segmentación de mercado

Pharmaceutical Intermediates MarketTipo
  • BPM
  • No GMP
Pharmaceutical Intermediates MarketAplicaciones
  • antibióticos
  • Analgésicos antipiréticos
  • vitaminas
  • Otros
Pharmaceutical Intermediates MarketCanal de distribución
  • Distribuidor
  • Ventas Directas
Pharmaceutical Intermediates MarketGeografía
  • América del norte
  • Europa
  • Asia Pacífico
  • Medio Oriente y África
  • América del Sur y Central
  • El PDF de muestra muestra la estructura del contenido y la naturaleza de la información con análisis cualitativo y cuantitativo.

 

 

Perspectivas del mercado

 

 

Prevalencia creciente de enfermedades crónicas y enfermedades infecciosas

 

Los intermediarios farmacéuticos son los componentes básicos de los ingredientes farmacéuticos activos (API). Se trata de materias primas que sufren cambios moleculares o procesamiento durante la producción de medicamentos a granel. Por tanto, la necesidad de productos farmacéuticos intermedios aumenta con el aumento de la demanda de medicamentos para tratar enfermedades crónicas. Según los Centros para el Control y la Prevención de Enfermedades (CDC), 6 de cada 10 adultos en los EE. UU. padecen al menos una enfermedad crónica como cáncer, enfermedades cardíacas, pulmonares, accidentes cerebrovasculares, enfermedades neurológicas, diabetes y enfermedades renales. Además, 4 de cada 10 adultos en el país padecen dos o más enfermedades crónicas. Además, según el comunicado de prensa de la Alianza Europea de Enfermedades Crónicas (ECDA), en 2014, 9 de cada 10 personas en Europa mueren a causa de enfermedades crónicas. Así, entre el 70% y el 80% de los costes sanitarios totales se gastan en el tratamiento de enfermedades crónicas.

También es probable que la creciente prevalencia de enfermedades infecciosas, especialmente en el sudeste asiático, impulse la demanda de API en los próximos años, lo que eventualmente impulsará el crecimiento del mercado intermedio farmacéutico. Por ejemplo, según el Informe revisado del Programa Nacional de Control de la Tuberculosis, alrededor de 4,4 lakh de pacientes murieron debido a la tuberculosis en la India en 2018, es decir, el 29% del total de 1,5 millones de muertes causadas por la enfermedad en todo el mundo. Por lo tanto, una prevalencia tan alta de enfermedades crónicas e infecciosas está impulsando la demanda de medicamentos y, en última instancia, destacando la necesidad de intermediarios farmacéuticos.

 

Información basada en tipos

 

El mercado de productos intermedios farmacéuticos , por tipo, se segmenta en GMP y no GMP. El segmento GMP tuvo la mayor participación del mercado en 2020, mientras que se prevé que el mismo segmento registre la CAGR más alta del 4,4% en el mercado durante el período previsto.



 

Información basada en aplicaciones

 

El mercado de productos intermedios farmacéuticos, por aplicación, está segmentado en antibióticos, analgésicos antipiréticos, vitaminas y otros. El segmento de antibióticos tuvo la mayor participación del mercado en 2020; además, se prevé que este segmento registre la CAGR más alta del 4,9% en el mercado durante el período de pronóstico.

 


Información basada en el canal de distribución

 

Según el canal de distribución, el mercado de productos intermedios farmacéuticos se ha segmentado en distribuidor y venta directa. El segmento de ventas directas tuvo la mayor participación del mercado en 2020, y se estima que el segmento de distribuidores registrará la CAGR más alta del mercado del 4,2% durante el período previsto.

Las empresas que operan en el mercado de productos intermedios farmacéuticos están adoptando estrategias orgánicas, como lanzamientos y expansiones de productos, para ampliar su presencia y cartera de productos en todo el mundo, así como para abordar las crecientes demandas.

 

Alcance del informe de mercado de productos intermedios farmacéuticos

Atributo del informeDetalles
Tamaño del mercado en 202027,36 mil millones de dólares
Tamaño del mercado para 202837,29 mil millones de dólares
CAGR global (2020 - 2028)4,2%
Información histórica2018-2019
Período de pronóstico2021-2028
Segmentos cubiertosPor tipo
  • BPM
  • No GMP
Por aplicaciones
  • antibióticos
  • Analgésicos antipiréticos
  • vitaminas
  • Otros
Por canal de distribución
  • Distribuidor
  • Ventas Directas
Regiones y países cubiertosAmérica del norte
  • A NOSOTROS
  • Canadá
  • México
Europa
  • Reino Unido
  • Alemania
  • Francia
  • Rusia
  • Italia
  • El resto de Europa
Asia-Pacífico
  • Porcelana
  • India
  • Japón
  • Australia
  • Resto de Asia-Pacífico
América del Sur y Central
  • Brasil
  • Argentina
  • Resto de América del Sur y Central
Medio Oriente y África
  • Sudáfrica
  • Arabia Saudita
  • Emiratos Árabes Unidos
  • Resto de Medio Oriente y África
Líderes del mercado y perfiles clave de empresas
  •  
  • Pfizer Inc.
  • sanofi
  • BASF SE
  • Tecnología química Co., Ltd de Lianhe
  • Dishman Carbogen Amcis Ltd.
  • códice
  • Midas Pharma GmbH
  • Chiracon GmbH
  • Laboratorios Dextra Limited
  • El PDF de muestra muestra la estructura del contenido y la naturaleza de la información con análisis cualitativo y cuantitativo.

 

 

Por tipo

 

  • BPM
  • No GMP

 

Por aplicación

 

  • antibióticos
  • Analgésicos antipiréticos
  • vitaminas
  • Otros

 

Por canal de distribución

 

  • Distribuidor
  • Ventas Directas

 

Por geografía

 

  • América del norte

    • A NOSOTROS
    • Canadá
    • México
  • Europa

    • Alemania
    • Francia
    • Italia
    • Reino Unido
    • España
    • Suiza
    • Bélgica
    • Grecia
    • Noruega
    • Portugal
    • Suecia
    • República Checa
    • Croacia
    • Irlanda
    • Dinamarca
    • Holanda
    • Rusia
    • El resto de Europa
  • Asia Pacífico (APAC)

    • Porcelana
    • India
    • Corea del Sur
    • Japón
    • Australia
    • Resto de Asia Pacífico
  • Medio Oriente y África (MEA)

    • Sudáfrica
    • Arabia Saudita
    • Emiratos Árabes Unidos
    • Pavo
    • Resto de MEA
  • América del Sur y Central (SCAM)

    • Brasil
    • Argentina
    • Resto de ESTAFA

 

Perfiles de empresa

 

  • Pfizer, Inc.
  • Grupo Dishman
  • Laboratorios Dextra Limited
  • Sanofi Industrias Winthrop SA
  • Vertellus Holdings LLC
  • BASF SE
  • Lianhetech
  • códice
  • Midas Pharma GmbH
  • Chiracon GmbH
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the cost of Pharmaceutical Intermediates?

The costs of the Pharmaceutical Intermediates are much higher, and they may cost US$ 5–50, or more, per kgs. The cost may also differ from product to product types.

What are Pharmaceutical Intermediates?

Pharmaceutical intermediates are the raw materials used to manufacture active pharmaceutical ingredients for the final drug formulation. Pharmaceutical intermediates are used in the production of bulk drugs as well as for research and development purpose by various pharm and biopharma companies. Pharmaceutical intermediates are formed at the time of process of production or synthesis of active pharmaceutical ingredients.

What are the driving factors for the Pharmaceutical Intermediates market across the globe?

Key factors that are driving the market are to rising prevalence of chronic diseases and infectious diseases, and escalating investment by pharmaceutical companies in R&D activities. However, high cost of drug manufacturing hinders the market growth.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies - Pharmaceutical Intermediate Market

  1. Pfizer Inc.
  2. Sanofi
  3. BASF SE
  4. Lianhe Chemical Technology Co., Ltd
  5. Dishman Carbogen Amcis Ltd
  6. Codexis
  7. Midas Pharma GmbH
  8. chiracon GmbH
  9. Dextra Laboratories Limited
  10. Vertellus Holdings LLC

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.